Reply to M.-E. Percival et al and L.B. Saltz

Comment

Adil I Daud. J Clin Oncol. 2013.

. 2013 Jul 1;31(19):2515-6.

doi: 10.1200/JCO.2013.49.6703.

No abstract available

Comment on

Removing the unknown from the carcinoma of unknown primary.
Daud AI. Daud AI. J Clin Oncol. 2013 Jan 10;31(2):174-5. doi: 10.1200/JCO.2012.45.7630. Epub 2012 Dec 10. J Clin Oncol. 2013. PMID: 23233703 No abstract available.
Role of expression profiling in carcinoma of unknown primary remains unknown.
Saltz LB. Saltz LB. J Clin Oncol. 2013 Jul 1;31(19):2513-4. doi: 10.1200/JCO.2013.49.2264. Epub 2013 Jun 3. J Clin Oncol. 2013. PMID: 23733754 No abstract available.
Biased view of the role of site-specific therapy in carcinoma of unknown primary.
Percival ME, Colevas AD. Percival ME, et al. J Clin Oncol. 2013 Jul 1;31(19):2512-3. doi: 10.1200/JCO.2013.49.5036. Epub 2013 Jun 3. J Clin Oncol. 2013. PMID: 23733770 No abstract available.